FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4308432023> ?p ?o ?g. }

• W4308432023 endingPage "180" @default.
• W4308432023 startingPage "173" @default.
• W4308432023 abstract "Objective It remains unclear whether viral infections interfere with multiple sclerosis (MS) disease progression. We evaluated the prognostic role of antibody responses toward viruses determined at disease onset on long-term disease outcomes. Methods Humoral immune responses against Epstein-Barr virus (EBV)-encoded nuclear antigen EBNA1, viral capsid antigen (VCA) and early antigen, and toward cytomegalovirus (HCMV), human herpesvirus 6 and measles were investigated in a cohort of 143 patients with MS for their association with long-term disability and inflammation disease outcomes. Results Median (IQR) follow-up was 20 (17.2–22.8) years. In univariable analysis, increased HCMV levels were associated with a lower risk to Expanded Disability Status Scale 4.0 (HR 0.95; 95% CI 0.91 to 0.99; p=0.03), to develop a secondary progressive MS (HR 0.94; 95% CI 0.90 to 0.99; p=0.02) and to first-line treatment (HR 0.98; 95% CI 0.96 to 0.99; p=0.04). High HCMV IgG levels were associated with a longer time to first-line treatment (p=0.01). Increased immune responses against EBV-VCA were associated with higher risk for first-line (HR 1.45; 95% CI 1.12 to 1.88; p=0.005) and second-line treatments (HR 2.03; 95% CI 1.18 to 3.49; p=0.01), and high VCA IgG levels were associated with shorter time to first-line (p=0.004) and second-line (p=0.02) therapies. EBNA1-specific IgG levels correlated with disease severity (0.17; p=0.04) and with an increased relapse rate during follow-up (relapse rate 1.26; 95% CI 1.03 to 1.56; p=0.02) that remained stable in multivariable analysis. Conclusions These results indicate that elevated immune responses against HCMV at disease onset have protective effects on long-term disability and inflammation disease outcomes. Our data also indicate that increased immune responses against EBV in early phases may influence long-term disease prognosis." @default.
• W4308432023 created "2022-11-11" @default.
• W4308432023 creator A5015324959 @default.
• W4308432023 creator A5031171090 @default.
• W4308432023 creator A5034569366 @default.
• W4308432023 creator A5038434954 @default.
• W4308432023 creator A5045203220 @default.
• W4308432023 creator A5045918227 @default.
• W4308432023 creator A5063275381 @default.
• W4308432023 creator A5067229504 @default.
• W4308432023 creator A5088394311 @default.
• W4308432023 date "2022-11-07" @default.
• W4308432023 modified "2023-10-18" @default.
• W4308432023 title "Increased cytomegalovirus immune responses at disease onset are protective in the long-term prognosis of patients with multiple sclerosis" @default.
• W4308432023 cites W1545561875 @default.
• W4308432023 cites W1957027480 @default.
• W4308432023 cites W1980343850 @default.
• W4308432023 cites W1992958037 @default.
• W4308432023 cites W1995352677 @default.
• W4308432023 cites W2002670313 @default.
• W4308432023 cites W2019009797 @default.
• W4308432023 cites W2019329212 @default.
• W4308432023 cites W2040547343 @default.
• W4308432023 cites W2040558052 @default.
• W4308432023 cites W2056147058 @default.
• W4308432023 cites W2073917006 @default.
• W4308432023 cites W2074215315 @default.
• W4308432023 cites W2078229430 @default.
• W4308432023 cites W2080511279 @default.
• W4308432023 cites W2100298805 @default.
• W4308432023 cites W2103509557 @default.
• W4308432023 cites W2114299067 @default.
• W4308432023 cites W2119386841 @default.
• W4308432023 cites W2123509633 @default.
• W4308432023 cites W2134290014 @default.
• W4308432023 cites W2140407525 @default.
• W4308432023 cites W2162868909 @default.
• W4308432023 cites W2175756486 @default.
• W4308432023 cites W2184898873 @default.
• W4308432023 cites W2288914316 @default.
• W4308432023 cites W2293314724 @default.
• W4308432023 cites W2560140067 @default.
• W4308432023 cites W2583347849 @default.
• W4308432023 cites W2751587841 @default.
• W4308432023 cites W2789933865 @default.
• W4308432023 cites W2912853593 @default.
• W4308432023 cites W3026524899 @default.
• W4308432023 cites W3124877733 @default.
• W4308432023 cites W3169599583 @default.
• W4308432023 cites W4205972999 @default.
• W4308432023 doi "https://doi.org/10.1136/jnnp-2022-330205" @default.
• W4308432023 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36344261" @default.
• W4308432023 hasPublicationYear "2022" @default.
• W4308432023 type Work @default.
• W4308432023 citedByCount "3" @default.
• W4308432023 countsByYear W43084320232022 @default.
• W4308432023 countsByYear W43084320232023 @default.
• W4308432023 crossrefType "journal-article" @default.
• W4308432023 hasAuthorship W4308432023A5015324959 @default.
• W4308432023 hasAuthorship W4308432023A5031171090 @default.
• W4308432023 hasAuthorship W4308432023A5034569366 @default.
• W4308432023 hasAuthorship W4308432023A5038434954 @default.
• W4308432023 hasAuthorship W4308432023A5045203220 @default.
• W4308432023 hasAuthorship W4308432023A5045918227 @default.
• W4308432023 hasAuthorship W4308432023A5063275381 @default.
• W4308432023 hasAuthorship W4308432023A5067229504 @default.
• W4308432023 hasAuthorship W4308432023A5088394311 @default.
• W4308432023 hasConcept C126322002 @default.
• W4308432023 hasConcept C147483822 @default.
• W4308432023 hasConcept C159654299 @default.
• W4308432023 hasConcept C203014093 @default.
• W4308432023 hasConcept C207103383 @default.
• W4308432023 hasConcept C2522874641 @default.
• W4308432023 hasConcept C2776409557 @default.
• W4308432023 hasConcept C2777732132 @default.
• W4308432023 hasConcept C2779134260 @default.
• W4308432023 hasConcept C2779820661 @default.
• W4308432023 hasConcept C2780640218 @default.
• W4308432023 hasConcept C2780727368 @default.
• W4308432023 hasConcept C2780892749 @default.
• W4308432023 hasConcept C44249647 @default.
• W4308432023 hasConcept C71924100 @default.
• W4308432023 hasConcept C8891405 @default.
• W4308432023 hasConcept C90924648 @default.
• W4308432023 hasConceptScore W4308432023C126322002 @default.
• W4308432023 hasConceptScore W4308432023C147483822 @default.
• W4308432023 hasConceptScore W4308432023C159654299 @default.
• W4308432023 hasConceptScore W4308432023C203014093 @default.
• W4308432023 hasConceptScore W4308432023C207103383 @default.
• W4308432023 hasConceptScore W4308432023C2522874641 @default.
• W4308432023 hasConceptScore W4308432023C2776409557 @default.
• W4308432023 hasConceptScore W4308432023C2777732132 @default.
• W4308432023 hasConceptScore W4308432023C2779134260 @default.
• W4308432023 hasConceptScore W4308432023C2779820661 @default.
• W4308432023 hasConceptScore W4308432023C2780640218 @default.
• W4308432023 hasConceptScore W4308432023C2780727368 @default.
• W4308432023 hasConceptScore W4308432023C2780892749 @default.
• W4308432023 hasConceptScore W4308432023C44249647 @default.

• next